Boulevard, a client experience platform, has secured an $80M Series D round, fueling its growth in the medspa industry and setting a benchmark for AI-driven self-care in the evolving wellness business landscape.

Boulevard’s latest funding surge reflects its razor-sharp focus on self-care businesses. By targeting the medspa industry, Boulevard has crafted a platform that aligns directly with the needs of appointment-based businesses. Its tailored tech now powers nearly 15 percent of all medspas in the US, showcasing how personalized solutions outperform generic EMRs.

The medspa industry is booming; in the US alone, there are now over 10,000 facilities generating roughly $17 billion in annual revenue, according to industry watchdogs. Globally, the market value stood at $18.6 billion in 2023, with expectations to surge to between $45 billion and $49.4 billion by 2030, depending on the forecast model, at a projected CAGR of 13–15 percent.

In the U.S., revenue alone reached $7.15 billion in 2023 and is projected to more than double to $17.6 billion by 2030, growing at roughly 13.7 percent annually. Industry reports also highlight that average spend per visit sits near $536, driven by procedures like injectables, lasers, and chemical peels.

The platform’s intuitive features help businesses handle everything, from booking and messaging to payments and marketing, while simplifying client interactions. As a result, it processed nearly $5 billion in payments this year alone, representing a significant leap from prior years.

AI-Driven Innovation Accelerates Growth

Backed by JMI Equity, Index Ventures, and VMG Partners, Boulevard plans to expand its AI-driven self-care offerings. These innovations include smarter scheduling systems and predictive tools that increase appointment show rates. With over 2 million appointments booked monthly, Boulevard has tapped into a major behavioral shift, clients expect seamless digital experiences.

CEO Matt Danna noted that the beauty and medical services industries are merging rapidly. Recognizing this transformation early, Boulevard embedded flexibility into its system. That foresight helped Boulevard scale fast, especially as medspas shifted away from outdated platforms.

With the new $80 million Series D, Boulevard intends to expand across new self-care verticals and enhance its enterprise capabilities. The funding will also improve its client experience platform through the addition of new features and broader integrations. This includes further AI enhancements designed to maximize revenue, reduce no-shows, and streamline multi-location management.

Matt Emery of JMI Equity has joined the board, bringing a strong strategic focus as the company scales its operations. Boulevard’s founders, CEO Matt Danna and CTO Sean Stavropoulos, credit much of their success to deep field research and direct collaboration with business owners.

Boulevard, A Wellness Business Success Story

Since 2016, Boulevard has evolved from a niche salon software provider into a powerhouse for transforming wellness businesses. Over 40,000 professionals now use the platform across more than 5,000 businesses. Their explosive 500 percent revenue growth over the past three years demonstrates the power of a tech-driven customer experience.

By integrating payment systems and AI into a single platform, Boulevard has created a smarter workflow that eliminates friction. In turn, it has become a lifeline for medspas seeking speed, simplicity, and scalability.

Looking ahead, Boulevard will continue evolving its AI architecture, optimizing everything from client recommendations to operational efficiency. This mission is to create intuitive, high-performance software for the self-care industry that resonates with wellness businesses navigating a rapidly changing digital economy.

With its focus firmly on innovation, personalization, and reliability, Boulevard stands poised to redefine what a client experience platform can offer.

Follow USTechTimes on Facebook, Twitter and Linkedin for in-depth news of market trends, funding updates, and regulatory changes affecting startups in USA.

We Recommend: